Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | TNFAIP1 | Human | (+)-schisandrin B | multiple interactions | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TNFAIP1 mRNA] | CTD | PMID:31150632 | TNFAIP1 | Human | (-)-citrinin | increases expression | EXP | | 6480464 | Citrinin results in increased expression of TNFAIP1 mRNA | CTD | PMID:30428381 | TNFAIP1 | Human | (-)-citrinin | multiple interactions | EXP | | 6480464 | [Citrinin co-treated with ochratoxin A] results in decreased expression of TNFAIP1 mRNA | CTD | PMID:30428381 | TNFAIP1 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Tnfaip1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TNFAIP1 mRNA | CTD | PMID:36331819 | TNFAIP1 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Tnfaip1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TNFAIP1 mRNA | CTD | PMID:22206623 | TNFAIP1 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of TNFAIP1 mRNA | CTD | PMID:30165855 | TNFAIP1 | Human | 1H-pyrazole | increases expression | ISO | Tnfaip1 (Mus musculus) | 6480464 | pyrazole results in increased expression of TNFAIP1 mRNA | CTD | PMID:17945193 | TNFAIP1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Tnfaip1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of TNFAIP1 mRNA | CTD | PMID:21570461 | TNFAIP1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TNFAIP1 mRNA | CTD | PMID:33387578 | TNFAIP1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFAIP1 mRNA | CTD | PMID:34747641 | TNFAIP1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Tnfaip1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFAIP1 mRNA | CTD | PMID:15034205 | TNFAIP1 | Human | 2,4-dinitrotoluene | affects expression | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of TNFAIP1 mRNA | CTD | PMID:21346803 | TNFAIP1 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of TNFAIP1 mRNA | CTD | PMID:21179406 | TNFAIP1 | Human | 4-amino-2,6-dinitrotoluene | affects expression | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | 4-amino-2 and 6-dinitrotoluene affects the expression of TNFAIP1 mRNA | CTD | PMID:21346803 | TNFAIP1 | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | Tnfaip1 (Mus musculus) | 6480464 | Fenretinide results in increased expression of TNFAIP1 mRNA | CTD | PMID:28973697 | TNFAIP1 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of TNFAIP1 mRNA | CTD | PMID:30047161 | TNFAIP1 | Human | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TNFAIP1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TNFAIP1 mRNA | CTD | PMID:32699268 | TNFAIP1 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of TNFAIP1 mRNA | CTD | PMID:23724009 | TNFAIP1 | Human | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TNFAIP1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TNFAIP1 mRNA | CTD | PMID:32699268 | TNFAIP1 | Human | amitrole | increases expression | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of TNFAIP1 mRNA | CTD | PMID:30047161 | TNFAIP1 | Human | benzo[a]pyrene | decreases expression | ISO | Tnfaip1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of TNFAIP1 mRNA | CTD | PMID:15034205 and PMID:21715664 | TNFAIP1 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of TNFAIP1 3' UTR | CTD | PMID:27901495 | TNFAIP1 | Human | beta-lapachone | increases expression | EXP | | 6480464 | beta-lapachone results in increased expression of TNFAIP1 mRNA | CTD | PMID:38218311 | TNFAIP1 | Human | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Tnfaip1 (Mus musculus) | 6480464 | MIR93 inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TNFAIP1 protein] and TNFAIP1 protein affects the reaction [Diethylhexyl Phthalate results in increased ubiquitination of CSNK2B protein] | CTD | PMID:37302538 | TNFAIP1 | Human | bis(2-ethylhexyl) phthalate | increases expression | ISO | Tnfaip1 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of TNFAIP1 protein | CTD | PMID:37302538 | TNFAIP1 | Human | bisphenol A | increases expression | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of TNFAIP1 mRNA | CTD | PMID:25181051 | TNFAIP1 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of TNFAIP1 mRNA | CTD | PMID:29275510 | TNFAIP1 | Human | cadmium dichloride | increases methylation | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased methylation of TNFAIP1 promoter | CTD | PMID:22457795 | TNFAIP1 | Human | chlorpyrifos | increases expression | ISO | Tnfaip1 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of TNFAIP1 mRNA | CTD | PMID:37019170 | TNFAIP1 | Human | clofibric acid | multiple interactions | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TNFAIP1 mRNA | CTD | PMID:17602206 | TNFAIP1 | Human | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of TNFAIP1 mRNA | CTD | PMID:19320972 | TNFAIP1 | Human | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFAIP1 mRNA | CTD | PMID:19167446 | TNFAIP1 | Human | cycloheximide | multiple interactions | ISO | Tnfaip1 (Mus musculus) | 6480464 | TNFAIP1 protein inhibits the reaction [Cycloheximide results in decreased degradation of CSNK2B protein] | CTD | PMID:37302538 | TNFAIP1 | Human | diazinon | increases methylation | EXP | | 6480464 | Diazinon results in increased methylation of TNFAIP1 gene | CTD | PMID:22964155 | TNFAIP1 | Human | dibutyl phthalate | increases expression | ISO | Tnfaip1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of TNFAIP1 mRNA | CTD | PMID:21266533 | TNFAIP1 | Human | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFAIP1 mRNA | CTD | PMID:19167446 | TNFAIP1 | Human | fenthion | decreases expression | ISO | Tnfaip1 (Mus musculus) | 6480464 | Fenthion results in decreased expression of TNFAIP1 mRNA | CTD | PMID:34813904 | TNFAIP1 | Human | folic acid | multiple interactions | ISO | Tnfaip1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TNFAIP1 mRNA | CTD | PMID:22206623 | TNFAIP1 | Human | ketamine | decreases expression | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | Ketamine results in decreased expression of TNFAIP1 mRNA | CTD | PMID:20080153 | TNFAIP1 | Human | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of TNFAIP1 mRNA | CTD | PMID:31059760 | TNFAIP1 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of TNFAIP1 mRNA | CTD | PMID:31059760 | TNFAIP1 | Human | methimazole | increases expression | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of TNFAIP1 mRNA | CTD | PMID:30047161 | TNFAIP1 | Human | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | Tnfaip1 (Mus musculus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [TNFAIP1 protein results in increased degradation of CSNK2B protein] | CTD | PMID:37302538 | TNFAIP1 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TNFAIP1 mRNA | CTD | PMID:17602206 | TNFAIP1 | Human | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of TNFAIP1 mRNA | CTD | PMID:23195993 | TNFAIP1 | Human | ochratoxin A | multiple interactions | EXP | | 6480464 | [Citrinin co-treated with ochratoxin A] results in decreased expression of TNFAIP1 mRNA | CTD | PMID:30428381 | TNFAIP1 | Human | ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of TNFAIP1 mRNA | CTD | PMID:30428381 | TNFAIP1 | Human | oxaliplatin | multiple interactions | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of TNFAIP1 mRNA | CTD | PMID:25729387 | TNFAIP1 | Human | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TNFAIP1 mRNA more ... | CTD | PMID:32699268 | TNFAIP1 | Human | p-menthan-3-ol | decreases expression | EXP | | 6480464 | Menthol results in decreased expression of TNFAIP1 mRNA | CTD | PMID:26760959 | TNFAIP1 | Human | paracetamol | affects expression | ISO | Tnfaip1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of TNFAIP1 mRNA | CTD | PMID:17562736 | TNFAIP1 | Human | paracetamol | decreases expression | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of TNFAIP1 mRNA | CTD | PMID:33387578 | TNFAIP1 | Human | paracetamol | multiple interactions | EXP | | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of TNFAIP1 mRNA | CTD | PMID:31059760 | TNFAIP1 | Human | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of TNFAIP1 mRNA | CTD | PMID:31059760 | TNFAIP1 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of TNFAIP1 mRNA | CTD | PMID:21420995 | TNFAIP1 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Tnfaip1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TNFAIP1 mRNA | CTD | PMID:36331819 | TNFAIP1 | Human | pirinixic acid | decreases expression | ISO | Tnfaip1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of TNFAIP1 mRNA | CTD | PMID:17426115 | TNFAIP1 | Human | rotenone | decreases expression | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | Rotenone results in decreased expression of TNFAIP1 mRNA | CTD | PMID:19013527 | TNFAIP1 | Human | streptozocin | multiple interactions | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | [Streptozocin co-treated with Dietary Fats] results in increased expression of TNFAIP1 mRNA | CTD | PMID:20665664 | TNFAIP1 | Human | sulfadimethoxine | increases expression | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of TNFAIP1 mRNA | CTD | PMID:30047161 | TNFAIP1 | Human | tetrachloromethane | increases expression | ISO | Tnfaip1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of TNFAIP1 mRNA | CTD | PMID:27339419 and PMID:31919559 | TNFAIP1 | Human | tetrachloromethane | multiple interactions | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TNFAIP1 mRNA] | CTD | PMID:31150632 | TNFAIP1 | Human | tetrachloromethane | increases expression | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of TNFAIP1 mRNA | CTD | PMID:31150632 | TNFAIP1 | Human | thioacetamide | increases expression | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of TNFAIP1 mRNA | CTD | PMID:34492290 | TNFAIP1 | Human | titanium dioxide | decreases methylation | ISO | Tnfaip1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of TNFAIP1 promoter alternative form | CTD | PMID:35295148 | TNFAIP1 | Human | topotecan | multiple interactions | ISO | Tnfaip1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of TNFAIP1 mRNA | CTD | PMID:25729387 | TNFAIP1 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of TNFAIP1 mRNA | CTD | PMID:23179753 | TNFAIP1 | Human | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of TNFAIP1 gene | CTD | PMID:29154799 | |